Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal Assessment of Serology and Effectiveness to Determine COVID-19 Vaccine Correlates of Risk (CoR) and Correlates of Protection (CoP) in a Heterogeneous US Population Through Use of Decentralized Sites and Approaches for Data/Specimen Collection

NCT06761612 is registered in ClinicalTrials.gov with Biomedical Advanced Research and Development Authority as lead sponsor.

NCT NCT06761612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06761612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal Assessment of Serology and Effectiveness to Determine COVID-19 Vaccine Correlates of Risk (CoR) and Correlates of Protection (CoP) in a Heterogeneous US Population Through Use of Decentralized Sites and Approaches for Data/Specimen Collection
Lead sponsor
Biomedical Advanced Research and Development Authority
Phase
Observational
Overall status
Completed
Start date
October 19, 2024
Completion date
May 14, 2026
Enrollment
2,519 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

covid - 19